# A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

> **NCT04154501** · PHASE1 · COMPLETED · sponsor: **Centrexion Therapeutics** · enrollment: 68 (actual)

## Conditions studied

- Chronic Pain
- Nociceptive Pain
- Pain

## Interventions

- **DRUG:** CNTX-6016
- **OTHER:** Other: Placebo

## Key facts

- **NCT ID:** NCT04154501
- **Lead sponsor:** Centrexion Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-04
- **Primary completion:** 2019-08-21
- **Final completion:** 2019-08-26
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04154501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04154501, "A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04154501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*